CorMedix (CRMD) Surges After Posting $108.6M Net Income in Q3 2025
CorMedix Inc. (NASDAQ:CRMD) is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, dedicated to developing and commercializing…
UnitedHealthcare (UNH) Hits $87.1 B Revenue in Q3
UnitedHealth Group Incorporated (NYSE:UNH) is the largest healthcare company in the world by revenue, a Fortune 5 powerhouse…
Why Sensus Healthcare (SRTS) Could Be a Hidden Med-Tech Gem in 2026
Sensus Healthcare Inc. (NASDAQ:SRTS) is a pioneering medical device company that specializes in the development and commercialization of…
Why Alpha Cognition (ACOG) Could Be the Next Big Alzheimer’s Breakthrough Stock
Alpha Cognition Inc. (NASDAQ:ACOG) is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for neurodegenerative…
Apyx Medical (APYX) Surges 15% After Record Q3 Revenue of $12.9M
Apyx Medical Corporation (NASDAQ:APYX) is a leading advanced energy medical technology company that specializes in developing, manufacturing, and…
Tandem Diabetes Care (TNDM) Hits $249M Q3 Revenue Record
Tandem Diabetes Care Inc. (NASDAQ:TNDM) is a leading medical technology company revolutionizing insulin delivery and diabetes management through…
Natural Health Trends (NHTC) Q3 Revenue Falls 11% to $9.5 M
Natural Health Trends Corp. (NASDAQ:NHTC) is a global direct-selling and e-commerce company that develops and markets premium health,…
Globus Medical (GMED) Raises 2025 Revenue Guidance to $2.9 B—Here’s What It Means
Globus Medical Inc. (NYSE:GMED) is a leading global medical technology company dedicated to advancing the treatment of musculoskeletal…
LifeStance (LFST) Soars Nearly 30% After Q3 2025 Revenue Hits $363.8M
LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the largest and fastest-growing providers of outpatient mental health care…
Penumbra (PEN) Reports $355M Revenue & 29% EPS Beat
Penumbra Inc. (NYSE:PEN) is a global medical technology company headquartered in Alameda, California, recognized as one of the…
UroGen (URGN)’s UGN-103 Delivers 77.8% Success Rate
UroGen Pharma Ltd. (NASDAQ:URGN) is a late-stage biotechnology company pioneering a new standard of care in the treatment…
Here’s Why Viridian Therapeutics (VRDN) Is a Strong Buy
Viridian Therapeutics Inc. (NASDAQ:VRDN) is a clinical-stage biotechnology company dedicated to developing best-in-class medicines for serious and rare…
Why Cytek Biosciences (CTKB) Could Be a Hidden MedTech Gem
Cytek Biosciences, Inc. (NASDAQ:CTKB) is a leading global life sciences company that has redefined the field of cell…
Tectonic Therapeutics (TECX) Surges on Positive TX45 Trial Data
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is a clinical-stage biotechnology company headquartered in Watertown, Massachusetts, focused on transforming the…
Iovance Bio (IOVA): The Most Undervalued Cancer Stock in the Market
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is a pioneering biotechnology company dedicated to transforming cancer treatment through cell-based immunotherapies…
Can Aimei Health (AFJK) Defy Weiss Ratings’ Bearish Call?
Aimei Health Technology (NASDAQ:AFJK) is a special purpose acquisition company (SPAC) listed on the NASDAQ under the ticker…
Innoviva (INVA) Surges After Record Q3 2025 Earnings
Innoviva Inc. (NASDAQ:INVA) is a diversified healthcare and biopharmaceutical company based in Burlingame, California, known for its strong…
Why Analysts See Guardant Health (GH) Rallying to $249
Guardant Health Inc. (NASDAQ:GH) is a leading precision oncology company headquartered in Palo Alto, California, dedicated to transforming…